Pet Vaccine Market to Witness Huge Growth by 2026 | Zoetis, Merck Sharp & Dohme, Bayer, Elanco

AMA Research added a comprehensive research document of 200+ pages on ‘Pet Vaccine’ market  with detailed insights on growth factors and strategies. The study segments key regions that includes North America, Europe, Asia-Pacific with country level break-up and provide volume* and value related cross segmented information by each country. Some of the important players from a wide list of coverage used under bottom-up approach are Zoetis (United States), Merck Sharp & Dohme Corp. (United States), Bayer AG (Germany), Elanco US Inc. (United States) , Merial Inc. (United Kingdom), Virbac (France), Phibro Animal Health Corp. (United States), Boehringr Ingelheim GmbH (Germany), Tianjin Ringpu Bio-Technology Co., Ltd (China), Ceva (United States), Vetoquinol (France), Diamond Animal Healthcare (United States), India Immunological Ltd. (India), Sanofi S.A. (France), PHL Associates, Inc. (United States), Hygieia Biological Laboratories (United States), Colorado Serum Company (United States), Arko Laboratories, Ltd. (United States), Intervacc AB (Sweden)


Discover all statistics and data on Impact of COVID-19 on the global Pet Vaccine markets now. Get reliable information about competitor’s moves and strategies which are of immense significance for further planning.


Request a sample report @


According to The European Pet Food Industry, there are approximately 80 million European households who own at least one pet animal. People having animal pets as cats, dogs rabbit etc can have weakened immune systems so it is advisable to take extra precautions when choosing and handling pets. Animal vaccines help to control disease like rabies which can affect the pet holders hence the need for pet vaccines is propelling the Global PetVaccine Market. There are approximately 59000 people who die of rabies every year according to the Center for Disease Control. Parenteral animal rabies vaccines are administered under the supervision of the veterinarian. Pet vaccines account for 38% of the Global market with CAGR of 6.8% during 2018-2026. Some common dog pet vaccines include shots for canine distemper, measles, parvovirus, cav-2 for hepatitis, rabies, parainfluenza, bordetella, leptospirosis, lyme, coronavirus and giardia. Few Feline pet vaccines are available to prevent conditions including feline rhinotracheitis, feline calicivirus, feline distemper, feline panleukopenia, feline leukemia virus, feline immunodeficiency virus and feline infectious peritonitis and Chlamydia. Moreover, Not all cats need all the pet vaccinations and what they need will also vary on their age.


Market Segmentation

by  Type (Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines), Mode of Administration (Injectable Vaccines, Intranasal Vaccines), Vaccination (Canine Family, Core Vaccines, Non-core Vaccines, Feline Family)


Check for Discount @


Highlights of Influencing Trends: Increased prevalence of disease like rabies among pet animals and the probability of transmission of this disease to the pet holders

Increasing ownership of pets and great demand for dairy products.


Market Growth Drivers: Growing adoption rate of pets among pet owners

Increasing community awareness regarding health of pets

The Government initiatives creating awareness about pet vaccines.


Restraints: Rising maintenance cost for vaccine storage

Lack of awareness about pet vaccines among pet holders in underdeveloped countries and its need for the administration to the pets are hampering the market.


Challenges: Strict government regulations impacting the Global pet vaccine market is posing a challenge for this market.


View Detailed Table of Content @


Country level Break-up includes:

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Netherlands, Switzerland, Nordic, Others)

Asia-Pacific (Japan, China, Australia, India, Taiwan, South Korea, Middle East & Africa, Others)


On Special Request we do offer a dedicated and focus report on regional or by country level scope.

GET FULL COPY OF Latest Published COVID-19 Impact Analysis Study of United States Pet Vaccine Market @ ——— USD 2000

And, Asia-Pacific Pet Vaccine market study with Commentary on COVID-19 Impact Analysis on Sales Growth @ ——— USD 2500

Strategic Points Covered in Table of Content of Global Pet Vaccine Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Pet Vaccine market

Chapter 2: Exclusive Summary – the basic information of the Pet Vaccine Market.

Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Pet Vaccine

Chapter 4: Presenting the Pet Vaccine Market Factor Analysis, Post COVID Impact Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.

Chapter 5: Displaying the by Type, End User and Region 2014-2019

Chapter 6: Evaluating the leading manufacturers of the Pet Vaccine market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile

Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions (2020-2025)

Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

How Research Study of AMA helps clients in their decision making:

  • Creating strategies for new product development
  • Supporting & Adjust Investment/business decisions
  • Benchmark and judge own competitiveness
  • Aiding in the business planning process
  • Serving as a credible, independent check on company internal forecasts
  • Supporting acquisition strategies


Buy this report @


Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Author:

Advance Market Analytics is Global leaders of Market Research Industry provides the quantified B2B research to Fortune 500 companies on high growth emerging opportunities which will impact more than 80% of worldwide companies’ revenues.

Our Analyst is tracking high growth study with detailed statistical and in-depth analysis of market trends & dynamics that provide a complete overview of the industry. We follow an extensive research methodology coupled with critical insights related industry factors and market forces to generate the best value for our clients. We Provides reliable primary and secondary data sources, our analysts and consultants derive informative and usable data suited for our clients business needs. The research study enable clients to meet varied market objectives a from global footprint expansion to supply chain optimization and from competitor profiling to M&As.

Contact Us:
Craig Francis (PR & Marketing Manager)
AMA Research & Media LLP
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
[email protected]

Connect with us at